Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-21-015845
Filing Date
2021-07-01
Accepted
2021-07-01 16:15:38
Documents
2
Period of Report
2021-06-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1632
2 ex24-1.htm EX-24.1 17553
  Complete submission text file 0001493152-21-015845.txt   20670
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Issuer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O LINEAGE CELL THERAPEUTICS, INC. 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008
Business Address
Cook Kevin Leon (Reporting) CIK: 0001870539 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-12830 | Film No.: 211066012